For Q3, total net sales were $905 million, up 10% to last year and up 5% to pre-pandemic levels.
Net income per diluted share on an adjusted non-GAAP basis was $0.86 compared to $0.76 last year.
Recently, our Board of Directors approved a new share repurchase authorization of $500 million, replacing the February 2021 share repurchase program.
